Terms: = Lung cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
322 results:
1. Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell lung cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence.
Moulson R; Law J; Sacher A; Liu G; Shepherd FA; Bradbury P; Eng L; Iczkovitz S; Abbie E; Elia-Pacitti J; Ewara EM; Mokriak V; Weiss J; Pettengell C; Leighl NB
Curr Oncol; 2024 Apr; 31(4):1947-1960. PubMed ID: 38668049
[TBL] [Abstract] [Full Text] [Related]
2. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
3. Prophylactic Cranial Irradiation in Limited-Stage Small Cell lung cancer: A Meta-Analysis.
Chi C; Wang C; Dong L; Li X; Xu L
J Coll Physicians Surg Pak; 2024 Apr; 34(4):461-467. PubMed ID: 38576291
[TBL] [Abstract] [Full Text] [Related]
4. An
Thor M; Lee C; Sun L; Patel P; Apte A; Grkovski M; Shepherd AF; Gelblum DY; Wu AJ; Simone CB; Chaft JE; Rimner A; Gomez DR; Deasy JO; Shaverdian N
J Nucl Med; 2024 Apr; 65(4):520-526. PubMed ID: 38485270
[TBL] [Abstract] [Full Text] [Related]
5. Combination tumor-treating fields treatment for patients with metastatic non-small cell lung cancer: A cost-effectiveness analysis.
Liu K; Zhu Y; Zhu H; Zeng M
Cancer Med; 2024 Mar; 13(5):e7070. PubMed ID: 38468503
[TBL] [Abstract] [Full Text] [Related]
6. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors.
Hussain S; Mursal M; Verma G; Hasan SM; Khan MF
Eur J Pharmacol; 2024 May; 970():176484. PubMed ID: 38467235
[TBL] [Abstract] [Full Text] [Related]
7. Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.
Zupanc C; Franko A; Štrbac D; Kovač V; Dolžan V; Goričar K
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203360
[TBL] [Abstract] [Full Text] [Related]
8. Ct-based subregional radiomics using hand-crafted and deep learning features for prediction of therapeutic response to anti-PD1 therapy in NSCLC.
Hu Y; Jiang T; Wang H; Song J; Yang Z; Wang Y; Su J; Jin M; Chang S; Deng K; Jiang W
Phys Med; 2024 Jan; 117():103200. PubMed ID: 38160516
[TBL] [Abstract] [Full Text] [Related]
9. Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis.
Shimizu T; Inoue E; Ohkuma R; Kobayashi S; Tsunoda T; Wada S
Front Immunol; 2023; 14():1308381. PubMed ID: 38115995
[TBL] [Abstract] [Full Text] [Related]
10. ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.
Chen J; Sathiaseelan V; Reddy Chilamakuri CS; Roamio Franklin VN; Jakwerth CA; D'Santos C; Ringshausen I
Blood Adv; 2024 Mar; 8(5):1167-1178. PubMed ID: 38113463
[TBL] [Abstract] [Full Text] [Related]
11. Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells.
Xia L; Liu JY; Yang MY; Zhang XH; Jiang Y; Yin QQ; Luo CH; Liu HC; Kang ZJ; Zhang CT; Gao BB; Zhou AW; Cai HY; Waller EK; Yan JS; Lu Y
Cancer Res; 2024 Feb; 84(3):479-492. PubMed ID: 38095536
[TBL] [Abstract] [Full Text] [Related]
12. Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer.
Haragan A; Parashar P; Bury D; Cross G; Gosney JR
J Clin Pathol; 2024 Jan; 77(2):140-144. PubMed ID: 38071529
[TBL] [Abstract] [Full Text] [Related]
13. Increase in the Life Expectancy of Patients with cancer in the United States.
Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
[TBL] [Abstract] [Full Text] [Related]
14. Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
[TBL] [Abstract] [Full Text] [Related]
15. Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101.
Kawashima Y; Ishimoto O; Miyauchi E; Sakakibara T; Harada T; Usui K; Inoue A; Sugawara S
Thorac Cancer; 2023 Sep; 14(27):2804-2810. PubMed ID: 37589158
[TBL] [Abstract] [Full Text] [Related]
16. Anlotinib exerts an anti-T-cell acute lymphoblastic leukemia effect in vitro and in vivo.
Zhang X; Geng L; Yang L; Wang Y; Zou Z; Zhang Y; Xu H; Lei H; Cao Y; Wu Y; Gu W; Zhou L
Cell Signal; 2023 Oct; 110():110837. PubMed ID: 37544636
[TBL] [Abstract] [Full Text] [Related]
17. Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study.
Simon TA; Suissa S; Boers M; Hochberg MC; Skovron ML; Askling J; Michaud K; Strangfeld A; Pedro S; Frisell T; Meissner Y; Dominique A; Gomez A
Semin Arthritis Rheum; 2024 Feb; 64():152240. PubMed ID: 37500379
[TBL] [Abstract] [Full Text] [Related]
18. Ponatinib: An update on its drug targets, therapeutic potential and safety.
Gao Y; Ding Y; Tai XR; Zhang C; Wang D
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188949. PubMed ID: 37399979
[TBL] [Abstract] [Full Text] [Related]
19. The clinicopathological spectrum and treatment outcomes in metastatic colorectal cancer in the KwaZulu-Natal province of South Africa.
Kader S; Moodley Y; Madiba TE
S Afr J Surg; 2023 Jun; 61(2):86-90. PubMed ID: 37381805
[TBL] [Abstract] [Full Text] [Related]
20. CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.
Alsadhan A; Chen J; Gaglione EM; Underbayev C; Tuma PL; Tian X; Freeman LA; Baskar S; Nierman P; Soto S; Itsara A; Ahn IE; Sun C; Bibikova E; Hartmann TN; Mhibik M; Wiestner A
Clin Cancer Res; 2023 Sep; 29(18):3612-3621. PubMed ID: 37227160
[TBL] [Abstract] [Full Text] [Related]
[Next]
